Last update 23 Jan 2025

Citrine Pharmaceutical (Shanghai) Co., Ltd.

Private Company|
2021|
Guangdong Sheng, China

Overview

Tags

Congenital Disorders
Nervous System Diseases
Endocrinology and Metabolic Disease
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
H3 receptor(Histamine H3 receptor)1

Related

2
Drugs associated with Citrine Pharmaceutical (Shanghai) Co., Ltd.
Setmelanotide Acetate
Target
MC4R
Mechanism
MC4R agonists
Active Org.
Rhythm Pharmaceuticals, Inc.Rhythm Pharmaceuticals, Inc. [+4]
Originator Org.
Ipsen SAIpsen SA
Active Indication
Bardet-Biedl Syndrome [+7]
Inactive Indication
Alstrom Syndrome [+8]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date25 Nov 2020
Pitolisant Hydrochloride
Target
H3 receptor
Mechanism
H3 receptor antagonists
Active Org.
Bioprojet Pharma SARLBioprojet Pharma SARL [+6]
Originator Org.
Bioprojet Pharma SARLBioprojet Pharma SARL
Active Indication
Excessive Daytime Sleepiness [+6]
Inactive Indication
Alcohol Use Disorder [+6]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
EU [+3]
First Approval Date31 Mar 2016
2
Clinical Trials associated with Citrine Pharmaceutical (Shanghai) Co., Ltd.
CTR20221411
/ CompletedPhase 1
中国健康受试者口服盐酸替洛利生薄膜衣片的开放、单次给药（随机）及多次给药的药代动力学研究
[Translation] An open-label, single-dose (randomized) and multiple-dose pharmacokinetic study of oral tilorexan hydrochloride film-coated tablets in healthy Chinese subjects
CTR20220114
/ CompletedPhase 3
评价盐酸替洛利生薄膜衣片治疗阻塞性睡眠呼吸暂停患者日间过度嗜睡有效性和安全性的随机、双盲、安慰剂对照、多中心临床研究
[Translation] A randomized, double-blind, placebo-controlled, multicenter clinical study to evaluate the efficacy and safety of tilorexan hydrochloride film-coated tablets in the treatment of excessive daytime sleepiness in patients with obstructive sleep apnea
100 Clinical Results associated with Citrine Pharmaceutical (Shanghai) Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Citrine Pharmaceutical (Shanghai) Co., Ltd.
Login to view more data
100 Deals associated with Citrine Pharmaceutical (Shanghai) Co., Ltd.
Login to view more data
100 Translational Medicine associated with Citrine Pharmaceutical (Shanghai) Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 16 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Approval
1
1
Phase 3 Clinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Pitolisant Hydrochloride
 ( H3 receptor )		Sleep Apnea, Obstructive
More
Phase 3
Setmelanotide Acetate
 ( MC4R )		Obesity
More
IND Approval
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free